Article
Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection.
Journal of viral hepatitis - 1 Apr 2011
Pedersen C, Alsiö Å, Lagging M, Langeland N, Färkkilä M, Buhl M Rauning, Mørch K, Westin J, Sangfelt P, Norkrans G, Christensen P Brehm
Abstract excerpt
In hepatitis C virus (HCV) genotype 1 infection, the likelihood of obtaining sustained virological response (SVR) is associated with higher ribavirin exposure. Such an association has not been demonstrated for HCV genotype 2/3 infection, where a fixed 800 mg daily dosing of ribavirin is generally recommended. The primary aim of this study was to investigate the correlation between ribavirin concentration at day...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.